Does Intellectual Property Laws in India and China Encourage Innovation?
Parama Sinha Palit, Bhaskar Bhattacharya
日本知財学会誌 Vol.4 No.3 p.82-88 (2008-3-20)
Journal of Intellectual Property Association of Japan Vol.4 No.3 p.82-88（2008-3-20）
Incremental innovation has become a point of debate the world over. While it is largely believed that ‘breakthrough’ innovations are important, at the same time it is held that such ‘breakthroughs’ are rare in medical research. India and China, the two Asian countries are not only joining the international trade as emerging economies but their pharmaceutical industry is also taking big strides. As far as the pharmaceutical industry is concerned, ‘minor’ but ‘essential’ steps are considered crucial for the industry to improve medicines and public health. However, there seems to be a dilemma amongst countries over the ‘value added’ by way of these small incremental changes. This paper attempts to examine both the Indian and the Chinese pharmaceutical industry and analyze the criticality of ‘incremental innovation’ for the industry in these two specific countries of interest.
Innovation, Incremental, Pharmaceutical, TRIPS, Healthcare, Patent